Table 1.
Antibiotic | Patients | Dose | Vd (l/kg) | CL (ml/min) | T½(h) | Cmax(mg/ml) | AUC (mg·h/L) | MIC targeted (mg/L) | PD target achieved | Reference |
---|---|---|---|---|---|---|---|---|---|---|
Cefepime |
12 |
2 g q12h |
0.34* |
123 |
3.2 |
|
346 |
4 |
77% T > MIC |
[18] |
19 |
2 g q8h |
0.36 |
88.2* |
3.37 |
68 |
310 |
32 |
34% T > 4xMIC |
[20] |
|
13 |
2 g q12h |
0.32* |
134 |
2.5 |
|
249 |
|
|
[33] |
|
7 |
2 g q12h |
0.47* |
125 |
3.42 |
|
305 |
7 |
80% T > MIC90 |
[19] |
|
5 |
100% T > MIC90 |
|||||||||
17 |
2 g q8h |
0.37 |
88.2* |
3.37 |
66.56 |
324.02 |
|
|
[34] |
|
Ceftazidime |
15 |
2 g q8h |
0.81* |
151 |
4.75 |
|
277.31 |
|
|
[21] |
12 |
2 g q8h |
0.27* |
|
3.48 |
124.4 |
331 |
4 |
92% T > MIC |
[35] |
|
17 |
2 g q8h |
0.51 |
63.7* |
6.28 |
61.65 |
523.49 |
|
|
[34] |
|
18 |
2 g q8h |
0.48 |
112* |
5.84 |
63 |
522 |
32 |
45% T > 4xMIC |
[20] |
|
10 |
2 g q8h |
0.23 |
112* |
1.98 |
|
|
|
|
[36] |
|
49 |
2 g q8h or 6 g CI/day |
0.67* |
91.3 |
|
|
|
|
|
[22] |
|
Meropenem |
8 |
2 g q8h or |
0.38* |
156.7 |
2.4 |
110.1 |
193.8 |
|
100% T > MIC |
[37] |
7 |
2 g LD + 3 g CI/day |
0.37* |
128.3 |
|
|
117.5 |
|
100% T > MIC |
||
16 |
1 g q8h |
0.43 |
130.9* |
2.05 |
35 |
132 |
8 |
57% T > 4xMIC |
[20] |
|
10 |
1 g q8h or 3 g CI/day |
0.32* |
226.7 |
|
|
|
|
|
[23] |
|
10 |
1 g q8h |
0.39* |
191 |
2.13 |
46.6 |
99.5 |
0.25-1 |
100% T > MIC |
[38] |
|
Piperacillin |
8 |
12/1.5 g PIP/TAZ CI |
0.33 |
286.7 |
|
144 |
|
|
|
[24] |
8 |
4/0.5 PIP/TAZ q6h or q8h |
|
266.6 |
|
|
|
||||
27 |
4 g q6h |
0.38 |
141.4* |
2.58 |
123 |
469 |
64 |
33% T > 4xMIC |
[20] |
|
Ceftriaxone |
54 |
2 g qd |
0.28* |
14.7 |
9.6 |
|
|
8 |
16% T > MIC |
[25] |
10 |
2 g qd |
0.28* |
41.3 |
6.4 |
204.9 |
|
|
|
[30] |
|
Ertapenem |
17 |
1 g CI/day |
0.21* |
43.2 |
4.15 |
90 |
418 |
2 |
25% T > MIC |
[39] |
8 |
1 g qd |
0.85* |
200.5 |
5.7 |
94.1 |
317.7 |
|
|
[26] |
|
Flucloxacillin | 10 | 0.29* | 150.2 | 2.45 | [27] |
Vd, volume of distribution; CL, clearance; Cmax, peak serum concentration; AUC, area under the concentration vs. time curve; MIC, minimum inhibitory concentration; CI, continuous infusion; LD, loading dose; PIP, piperacillin; TAZ, tazobactam; *Data were converted considering 70 kg body weight.